Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 4.8% in the morning session after Canaccord Genuity maintained its ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at life sciences tools & services stocks, ...

What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.5% in the afternoon session after several ...

At Pittcon, taking place in Chicago from 5-9 March, 2017, we will be joined by many of the leading manufacturers who are providing the tools and technologies powering these latest developments in ...

insights from industryDr. George EmanuelCo-Founder and Sr. Director of Technology & PartnershipsVizgen In this interview, we speak to Dr. George Emanuel, Scientific Co-Founder at Vizgen, about their ...

Scientists at the University of Virginia School of Medicine have developed important new resources that will aid the battle against cancer and advance cutting-edge genomics research. UVA’s Chongzhi ...

Precision medicine and genomics are innovations just starting to work their way into the mainstream of healthcare. And electronic health records are beginning to catch up with early use of precision ...

We anticipate that our Imaging-AMARETTO tools for network-based fusion of multiomics, clinical, and imaging data will directly lead to better diagnostic and prognostic models of cancer. In addition, ...

A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...

10x Genomics is partnering with Anthropic to integrate its single cell and spatial biology analysis tools into Claude for Life Sciences. Researchers can now perform advanced analytical tasks through ...

The three-dimensional (3D) architecture of interphase chromosomes is one of the most fascinating topological problems in biology. Decades of microscopy studies have revealed several important general ...